This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury

Sponsored by Emory University

About this trial

Last updated 8 months ago

Study ID

IRB00100619

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

The Focused Assessment with Sonography for Trauma (FAST) exam is widely used and accepted as part of advanced trauma life support (ATLS) protocol, but its low sensitivity for identifying solid organ injury in the absence of hemoperitoneum is a significant limitation. Contrast-enhanced ultrasound (CEUS) has the potential to significantly enhance the evaluation of the trauma patient with acute intra-abdominal injury through the use of intravascular microbubbles that allow direct visualization of lacerations to solid organs. European studies have demonstrated that ultrasound contrast markedly improves the sensitivity of ultrasound in detecting solid organ injury, when the exam is performed in the radiology suite. The researchers hypothesize that the bubble-enhanced FAST or BEFAST exam will be more sensitive than traditional FAST for identification of solid organ injury in hemodynamically stable blunt abdominal trauma patients when performed by emergency providers.

What are the participation requirements?

Yes

Inclusion Criteria

- Clinical suspicion of intra-abdominal injury

- Presentation within 24 hours of injury

- Planned CT of the abdomen/pelvis within 24 hours

- Ability of patient or legally authorized representative to provide informed consent

No

Exclusion Criteria

- Co-existing penetrating abdominal injury

- Known hypersensitivity reaction to contrast agent

- Pregnant patients

- Prisoners

- No appropriate IV Line able to be inserted

- Hemodynamic instability at time of enrollment (sustained systolic blood pressure < 90 mm Hg or sustained heart rate (HR) >120 despite initial resuscitation)

Locations

Location

Status